{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:46:56Z","timestamp":1791884816404,"version":"4.3.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07178-6","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:08:44Z","timestamp":1791878924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug repurposing of riluzole attenuates acquisition, accelerates extinction, and prevents reinstatement of ethanol-induced conditioned place preference"],"prefix":"10.1007","author":[{"given":"Andleeb","family":"Shahzadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oruc","family":"Yunusoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meliha","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D. E.","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"issue":"1","key":"7178_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12031-018-1194-z","volume":"67","author":"YS Althobaiti","year":"2018","unstructured":"Althobaiti YS, Alshehri FS, Hakami AY, Hammad AM, Sari Y (2018) Effects of Clavulanic Acid Treatment on Reinstatement to Methamphetamine, Glial Glutamate Transporters, and mGluR 2\/3 Expression in P Rats Exposed to Ethanol. J Mol Neurosci 67(1):1\u201315","journal-title":"J Mol Neurosci"},{"issue":"8","key":"7178_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3(8):673\u2013683","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"7178_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/BPL-190089","volume":"6","author":"Y Avchalumov","year":"2020","unstructured":"Avchalumov Y, Mandyam CD (2020) Synaptic Plasticity and its Modulation by Alcohol. Brain Plast 6(1):103\u2013111","journal-title":"Brain Plast"},{"issue":"1","key":"7178_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s002130000569","volume":"153","author":"MT Bardo","year":"2000","unstructured":"Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153(1):31\u201343","journal-title":"Psychopharmacology"},{"key":"7178_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/B978-0-444-62619-6.00009-4","volume":"125","author":"HC Becker","year":"2014","unstructured":"Becker HC, Mulholland PJ (2014) Neurochemical mechanisms of alcohol withdrawal. Handb Clin Neurol 125:133\u2013156","journal-title":"Handb Clin Neurol"},{"key":"7178_CR17","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/j.1530-0277.2009.00976.x","volume":"33 8","author":"J Besheer","year":"2009","unstructured":"Besheer J, Lepoutre V, Hodge C (2009) Preclinical evaluation of riluzole: assessments of ethanol self-administration and ethanol withdrawal symptoms. Alcohol Clin Exp Res 33 8:1460\u20131468","journal-title":"Alcohol Clin Exp Res"},{"issue":"8","key":"7178_CR36","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/j.1530-0277.2009.00976.x","volume":"33","author":"J Besheer","year":"2009","unstructured":"Besheer J, Lepoutre V, Hodge CW (2009) Preclinical Evaluation of Riluzole: Assessments of Ethanol Self-Administration and Ethanol Withdrawal Symptoms. Alcoholism: Clin Experimental Res 33(8):1460\u20131468","journal-title":"Alcoholism: Clin Experimental Res"},{"issue":"3","key":"7178_CR50","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00213-013-3120-y","volume":"229","author":"JM Bossert","year":"2013","unstructured":"Bossert JM, Marchant NJ, Calu DJ, Shaham Y (2013) The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology 229(3):453\u2013476","journal-title":"Psychopharmacology"},{"key":"7178_CR58","doi-asserted-by":"publisher","first-page":"7859","DOI":"10.1523\/JNEUROSCI.1902-04.2004","volume":"24","author":"E Carpenter-Hyland","year":"2004","unstructured":"Carpenter-Hyland E, Woodward J, Chandler L (2004) Chronic Ethanol Induces Synaptic But Not Extrasynaptic Targeting of NMDA Receptors. J Neurosci 24:7859\u20137868","journal-title":"J Neurosci"},{"issue":"10200","key":"7178_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0140-6736(19)31775-1","volume":"394","author":"AF Carvalho","year":"2019","unstructured":"Carvalho AF, Heilig M, Perez A, Probst C, Rehm J (2019) Alcohol use disorders. Lancet 394(10200):781\u2013792","journal-title":"Lancet"},{"issue":"12","key":"7178_CR31","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/jcbfm.2008.78","volume":"28","author":"GMI Chowdhury","year":"2008","unstructured":"Chowdhury GMI, Banasr M, de Graaf RA, Rothman DL, Behar KL, Sanacora G (2008) Chronic Riluzole Treatment Increases Glucose Metabolism in Rat Prefrontal Cortex and Hippocampus. J Cereb Blood Flow Metabolism 28(12):1892\u20131897","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"7178_CR29","doi-asserted-by":"crossref","unstructured":"Datta S, Rashid Z, Naskar S, Chattarji S (2023) Administration of the glutamate-modulating drug, riluzole, after stress prevents its delayed effects on the amygdala in male rats. PNAS Nexus 2(6):pgad166","DOI":"10.1093\/pnasnexus\/pgad166"},{"issue":"3","key":"7178_CR6","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/add.15647","volume":"117","author":"E Day","year":"2021","unstructured":"Day E, Daly C (2021) Clinical management of the alcohol withdrawal syndrome. Addiction 117(3):804\u2013814","journal-title":"Addiction"},{"issue":"2","key":"7178_CR60","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0014-2999(93)90147-A","volume":"235","author":"M-W Debono","year":"1993","unstructured":"Debono M-W, Le Guern J, Canton T, Doble A, Pradier L (1993) Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur J Pharmacol 235(2):283\u2013289","journal-title":"Eur J Pharmacol"},{"key":"7178_CR28","doi-asserted-by":"crossref","unstructured":"Dey S (2025) Integrative multi-omics based prediction of biomarkers across mood disorders (schizophrenia, major depressive disorder, and bipolar disorder). ResearchHub Technologies, Inc. 2025\/08\/22","DOI":"10.55277\/researchhub.ex2jdh9g"},{"issue":"4","key":"7178_CR46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1530-0277.2011.01665.x","volume":"36","author":"ZM Ding","year":"2012","unstructured":"Ding ZM, Engleman EA, Rodd ZA, McBride WJ (2012) Ethanol increases glutamate neurotransmission in the posterior ventral tegmental area of female wistar rats. Alcohol Clin Exp Res 36(4):633\u2013640","journal-title":"Alcohol Clin Exp Res"},{"key":"7178_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1212\/WNL.47.6_Suppl_4.233S","volume":"47","author":"A Doble","year":"1996","unstructured":"Doble A (1996) The pharmacology and mechanism of action of riluzole. Neurology 47:233\u2013241","journal-title":"Neurology"},{"issue":"6 Suppl 4","key":"7178_CR59","first-page":"S233","volume":"47","author":"A Doble","year":"1996","unstructured":"Doble A (1996) The pharmacology and mechanism of action of riluzole. Neurology 47(6 Suppl 4):S233\u2013S241","journal-title":"Neurology"},{"issue":"1","key":"7178_CR61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0014-2999(95)00186-O","volume":"280","author":"AG Estevez","year":"1995","unstructured":"Estevez AG, Stutzmann J-M, Barbeito L (1995) Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures. Eur J Pharmacol 280(1):47\u201353","journal-title":"Eur J Pharmacol"},{"key":"7178_CR53","doi-asserted-by":"publisher","first-page":"114089","DOI":"10.1016\/j.bbr.2022.114089","volume":"436","author":"I Fredriksson","year":"2023","unstructured":"Fredriksson I, Jayaram-Lindstr\u00f6m N, Kalivas PW, Melas PA, Steensland P (2023) N-acetylcysteine improves impulse control and attenuates relapse-like alcohol intake in long-term drinking rats. Behav Brain Res 436:114089","journal-title":"Behav Brain Res"},{"issue":"2\u20133","key":"7178_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejphar.2007.10.023","volume":"578","author":"E Fumagalli","year":"2008","unstructured":"Fumagalli E, Funicello M, Rauen T, Gobbi M, Mennini T (2008) Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur J Pharmacol 578(2\u20133):171\u2013176","journal-title":"Eur J Pharmacol"},{"key":"7178_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/bph.70206","volume":"183","author":"E Galaj","year":"2025","unstructured":"Galaj E, Inan S, Bi G-H, Wiah S, Adamson G, Reitz A et al (2025) Troriluzole attenuates opioid intake, reinforcing efficacy, seeking behaviours, physical dependence and antinociceptive tolerance in rats. Br J Pharmacol 183:505\u2013519","journal-title":"Br J Pharmacol"},{"issue":"22","key":"7178_CR23","doi-asserted-by":"publisher","first-page":"7562","DOI":"10.1523\/JNEUROSCI.5616-12.2014","volume":"34","author":"JT Gass","year":"2014","unstructured":"Gass JT, Trantham-Davidson H, Kassab AS, Glen WB, Olive MF, Chandler LJ (2014) Enhancement of Extinction Learning Attenuates Ethanol-Seeking Behavior and Alters Plasticity in the Prefrontal Cortex. J Neurosci 34(22):7562\u20137574","journal-title":"J Neurosci"},{"key":"7178_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neubiorev.2017.02.024","volume":"77","author":"S Goodwani","year":"2017","unstructured":"Goodwani S, Saternos H, Alasmari F, Sari Y (2017) Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder. Neurosci Biobehavioral Reviews 77:14\u201331","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"7178_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1089\/cap.2010.0009","volume":"20","author":"P Grant","year":"2010","unstructured":"Grant P, Song J, Swedo S (2010) Review of the Use of the Glutamate Antagonist Riluzole in Psychiatric Disorders and a Description of Recent Use in Childhood Obsessive-Compulsive Disorder. J Child Adolesc Psychopharmacol 20:309\u2013315","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"7178_CR62","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/jnc.15224","volume":"156","author":"KN Hascup","year":"2021","unstructured":"Hascup KN, Findley CA, Britz J, Esperant-Hilaire N, Broderick SO, Delfino K et al (2021) Riluzole attenuates glutamatergic tone and cognitive decline in A\u03b2PP\/PS1 mice. J Neurochem 156(4):513\u2013523","journal-title":"J Neurochem"},{"key":"7178_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1124\/jpet.106.111419","volume":"321","author":"A Hendricson","year":"2007","unstructured":"Hendricson A, Maldve R, Salinas A, Theile J, Zhang T, Diaz L et al (2007) Aberrant Synaptic Activation of N-Methyl-d-aspartate Receptors Underlies Ethanol Withdrawal Hyperexcitability. J Pharmacol Exp Ther 321:60\u201372","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"7178_CR8","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1111\/acer.12893","volume":"39","author":"AT Hillmer","year":"2015","unstructured":"Hillmer AT, Mason GF, Fucito LM, O\u2019Malley SS, Cosgrove KP (2015) How Imaging Glutamate, \u03b3-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal. Alcohol Clin Exp Res 39(12):2268\u20132282","journal-title":"Alcohol Clin Exp Res"},{"issue":"11","key":"7178_CR52","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1111\/j.1530-0277.1999.tb04070.x","volume":"23","author":"SN Katner","year":"1999","unstructured":"Katner SN, Weiss F (1999) Ethanol-associated olfactory stimuli reinstate ethanol-seeking behavior after extinction and modify extracellular dopamine levels in the nucleus accumbens. Alcohol Clin Exp Res 23(11):1751\u20131760","journal-title":"Alcohol Clin Exp Res"},{"key":"7178_CR1","doi-asserted-by":"crossref","unstructured":"Koob GF (2014) Frameworks of Alcohol Addiction. Neurobiology of Alcohol Dependence. Elsevier, pp 3\u201328","DOI":"10.1016\/B978-0-12-405941-2.00001-8"},{"issue":"1","key":"7178_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-pharmtox-031323-115847","volume":"64","author":"GF Koob","year":"2024","unstructured":"Koob GF (2024) Alcohol Use Disorder Treatment: Problems and Solutions. Annu Rev Pharmacol Toxicol 64(1):255\u2013275","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"7178_CR55","doi-asserted-by":"crossref","unstructured":"Lim JR, Lee HJ, Jung Y, Kim JS, Chae C, Kim SY et al (2019) Ethanol-activated CaMKII signaling induces neuronal apoptosis through Drp1-mediated excessive mitochondrial fission and JNK1-dependent NLRP3 inflammasome activation. Cell Communication and Signaling: CCS. ;18","DOI":"10.21203\/rs.2.18316\/v1"},{"key":"7178_CR18","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1100\/tsw.2008.154","volume":"8","author":"Y Liu","year":"2008","unstructured":"Liu Y, Le Foll B, Liu Y, Wang X, Lu L (2008) Conditioned Place Preference Induced by Licit Drugs: Establishment, Extinction, and Reinstatement. Sci World J 8:1228\u20131245","journal-title":"Sci World J"},{"key":"7178_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neulet.2019.04.021","volume":"704","author":"Z Liu","year":"2019","unstructured":"Liu Z, Xu Y, Zhang X, Miao J, Zhu Z (2019) Riluzole blocks HU210-facilitated ventral tegmental long-term depression by enhancing glutamate uptake in astrocytes. Neurosci Lett 704:201\u2013207","journal-title":"Neurosci Lett"},{"issue":"5","key":"7178_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41583-020-0289-z","volume":"21","author":"C L\u00fcscher","year":"2020","unstructured":"L\u00fcscher C, Robbins TW, Everitt BJ (2020) The transition to compulsion in addiction. Nat Rev Neurosci 21(5):247\u2013263","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"7178_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/187152710790966641","volume":"9","author":"BJ Mason","year":"2010","unstructured":"Mason BJ, Heyser CJ (2010) Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence. CNS Neurol Disord Drug Targets 9(1):23\u201332","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"7178_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00213-012-2686-0","volume":"221","author":"L Mattioli","year":"2012","unstructured":"Mattioli L, Titomanlio F, Perfumi M (2012) Effects of a Rhodiola rosea L. extract on the acquisition, expression, extinction, and reinstatement of morphine-induced conditioned place preference in mice. Psychopharmacology 221(2):183\u2013193","journal-title":"Psychopharmacology"},{"key":"7178_CR19","doi-asserted-by":"publisher","first-page":"582147","DOI":"10.3389\/fnbeh.2020.582147","volume":"14","author":"G McKendrick","year":"2020","unstructured":"McKendrick G, Graziane NM (2020) Drug-Induced Conditioned Place Preference and Its Practical Use in Substance Use Disorder Research. Front Behav Neurosci 14:582147","journal-title":"Front Behav Neurosci"},{"key":"7178_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ibneur.2024.11.015","volume":"18","author":"CK Murithi","year":"2025","unstructured":"Murithi CK, Kabaru JM, Patel NB (2025) Khat-induced conditioned place preference, extinction, and reinstatement in female mice. IBRO Neurosci Rep 18:1\u20135","journal-title":"IBRO Neurosci Rep"},{"key":"7178_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/157015908783769662","volume":"6","author":"J Nagy","year":"2008","unstructured":"Nagy J (2008) Alcohol Related Changes in Regulation of NMDA Receptor Functions. Curr Neuropharmacol 6:39\u201354","journal-title":"Curr Neuropharmacol"},{"key":"7178_CR4","unstructured":"Organization WH (2024) Global status report on alcohol and health and treatment of substance use disorders. [Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240096745"},{"key":"7178_CR26","doi-asserted-by":"publisher","first-page":"18733","DOI":"10.1073\/pnas.1421285111","volume":"111","author":"A Pereira","year":"2014","unstructured":"Pereira A, Lambert H, Grossman Y, Dumitriu D, Waldman R, Jannetty S et al (2014) Glutamatergic regulation prevents hippocampal-dependent age-related cognitive decline through dendritic spine clustering. Proc Natl Acad Sci 111:18733\u201318738","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"7178_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/acer.13931","volume":"43","author":"JJ Prisciandaro","year":"2019","unstructured":"Prisciandaro JJ, Schacht JP, Prescot AP, Renshaw PF, Brown TR, Anton RF (2019) Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Na\u00efve Individuals with Alcohol Use Disorder Versus Light Drinkers. Alcoholism: Clin Experimental Res 43(2):221\u2013226","journal-title":"Alcoholism: Clin Experimental Res"},{"issue":"1","key":"7178_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A et al (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18(1):41\u201358","journal-title":"Nat Rev Drug Discov"},{"key":"7178_CR3","doi-asserted-by":"crossref","unstructured":"Ramkissoon R, Shah VH (2022) Alcohol use disorder and alcohol-associated liver disease. Alcohol research: Curr Reviews 42(1):13","DOI":"10.35946\/arcr.v42.1.13"},{"key":"7178_CR10","doi-asserted-by":"crossref","unstructured":"Rao PSS, Bell RL, Engleman EA, Sari Y (2015) Targeting glutamate uptake to treat alcohol use disorders. Front NeuroSci 9:144","DOI":"10.3389\/fnins.2015.00144"},{"key":"7178_CR14","doi-asserted-by":"crossref","unstructured":"Rokade AV, Yelne P, Giri A (2022) Riluzole and Edavarone: The Hope Against Amyotrophic Lateral Sclerosis. Cureus","DOI":"10.7759\/cureus.30035"},{"issue":"2","key":"7178_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/picr.picr_70_24","volume":"16","author":"K Saranraj","year":"2025","unstructured":"Saranraj K, Kiran PU (2025) Drug repurposing: Clinical practices and regulatory pathways. Perspect Clin Res 16(2):61\u201368","journal-title":"Perspect Clin Res"},{"key":"7178_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuroscience.2016.04.004","volume":"326","author":"Y Sari","year":"2016","unstructured":"Sari Y, Toalston J, Rao P, Bell R (2016) Effects of ceftriaxone on ethanol, nicotine or sucrose intake by alcohol-preferring (P) rats and its association with GLT-1 expression. Neuroscience 326:117\u2013125","journal-title":"Neuroscience"},{"key":"7178_CR16","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/npp.2017.244","volume":"43","author":"M Sepulveda-Orengo","year":"2017","unstructured":"Sepulveda-Orengo M, Healey K, Kim R, Auriemma A, Rojas J, Woronoff N et al (2017) Riluzole Impairs Cocaine Reinstatement and Restores Adaptations in Intrinsic Excitability and GLT-1 Expression. Neuropsychopharmacology 43:1212\u20131223","journal-title":"Neuropsychopharmacology"},{"key":"7178_CR32","doi-asserted-by":"publisher","first-page":"855241","DOI":"10.3389\/fnbeh.2022.855241","volume":"16","author":"A Shahzadi","year":"2022","unstructured":"Shahzadi A, Yunusoglu O, Karabulut E, Sonmez H, Yazici Z (2022) Influence of Selective Dopamine Agonist Ropinirole on Conditioned Place Preference and Somatic Signs of Morphine Withdrawal in Rats. Front Behav Neurosci 16:855241","journal-title":"Front Behav Neurosci"},{"issue":"6","key":"7178_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0301-0082(98)00060-4","volume":"56","author":"TM Tzschentke","year":"1998","unstructured":"Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56(6):613\u2013672","journal-title":"Prog Neurobiol"},{"issue":"3\u20134","key":"7178_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","volume":"12","author":"TM Tzschentke","year":"2007","unstructured":"Tzschentke TM (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12(3\u20134):227\u2013462","journal-title":"Addict Biol"},{"issue":"3","key":"7178_CR30","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s13311-022-01339-z","volume":"20","author":"MT Usmani","year":"2023","unstructured":"Usmani MT, Krattli RP, El-Khatib SM, Le ACD, Smith SM, Baulch JE et al (2023) BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis. Neurotherapeutics 20(3):838\u2013852","journal-title":"Neurotherapeutics"},{"key":"7178_CR63","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.alcohol.2022.08.010","volume":"107","author":"V Vatsalya","year":"2023","unstructured":"Vatsalya V, Byrd ND, Stangl BL, Momenan R, Ramchandani VA (2023) Influence of age and sex on alcohol pharmacokinetics and subjective pharmacodynamic responses following intravenous alcohol exposure in humans. Alcohol 107:144\u2013152","journal-title":"Alcohol"},{"key":"7178_CR56","doi-asserted-by":"crossref","unstructured":"Xu M, Woodward J (2006) Ethanol inhibition of NMDA receptors under conditions of altered protein kinase A activity. J Neurochem 96:1760\u20131767","DOI":"10.1111\/j.1471-4159.2006.03703.x"},{"issue":"12","key":"7178_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/01616412.2021.1948749","volume":"43","author":"O Yunuso\u011flu","year":"2021","unstructured":"Yunuso\u011flu O (2021) Resveratrol impairs acquisition, reinstatement and precipitates extinction of alcohol-induced place preference in mice. Neurol Res 43(12):985\u2013994","journal-title":"Neurol Res"},{"key":"7178_CR35","doi-asserted-by":"publisher","first-page":"136383","DOI":"10.1016\/j.neulet.2021.136383","volume":"768","author":"O Yunuso\u011flu","year":"2022","unstructured":"Yunuso\u011flu O (2022) Evaluation of the effects of quercetin on the rewarding property of ethanol in mice. Neurosci Lett 768:136383","journal-title":"Neurosci Lett"},{"key":"7178_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.alcohol.2021.11.003","volume":"98","author":"O Yunuso\u011flu","year":"2022","unstructured":"Yunuso\u011flu O (2022) Rewarding effect of ethanol-induced conditioned place preference in mice: Effect of the monoterpenoid linalool. Alcohol 98:55\u201363","journal-title":"Alcohol"},{"issue":"4","key":"7178_CR44","first-page":"722","volume":"26","author":"O Yunuso\u011flu","year":"2025","unstructured":"Yunuso\u011flu O, Shahzadi A, Ak\u00fcnal T\u00fcrel C, Demirkol MH, Berk\u00f6z M, Akkan AG (2025) Investigation of the pharmacological potential of myricetin on alcohol addiction in mice. J Res Pharm 26(4):722\u2013733","journal-title":"J Res Pharm"},{"issue":"1","key":"7178_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0014-2999(93)90682-8","volume":"231","author":"ML Zeise","year":"1993","unstructured":"Zeise ML, Kasparov S, Capogna M, Zieglg\u00e4nsberger W (1993) Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors. Eur J Pharmacol 231(1):47\u201352","journal-title":"Eur J Pharmacol"},{"key":"7178_CR27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/npp.2017.300","volume":"43","author":"J Ziminski","year":"2018","unstructured":"Ziminski J, Koya E (2018) Reversing Cocaine-Induced Adaptations and Reducing Relapse: An Opportunity for Repurposing Riluzole. Neuropsychopharmacology 43:1197\u20131198","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"7178_CR51","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bbr.2005.09.007","volume":"167","author":"I Zironi","year":"2006","unstructured":"Zironi I, Burattini C, Aicardi G, Janak PH (2006) Context is a trigger for relapse to alcohol. Behav Brain Res 167(1):150\u2013155","journal-title":"Behav Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07178-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07178-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07178-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:02:14Z","timestamp":1791882134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07178-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":63,"alternative-id":["7178"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07178-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}